NFAT5 Antibody

What is NFAT5 and what cellular functions does it regulate?

NFAT5 is a ubiquitously expressed transcription factor involved in numerous cellular processes beyond osmotic regulation. NFAT5 binds to the DNA consensus sequence 5'-[ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3' and mediates transcriptional responses to hypertonicity . Recent research demonstrates that NFAT5 positively regulates transcription of multiple genes including LCN2 and S100A4, with optimal transactivation requiring DDX5/DDX17 . Beyond osmotic stress responses, NFAT5 participates in DNA damage response mechanisms by preventing formation of R-loops (DNA:RNA hybrids and associated non-template single-stranded DNA) . In the inner medullary collecting duct, NFAT5 has been identified as a direct transcriptional regulator of the EDN1 gene, pointing to its role in body Na+ homeostasis maintenance .

What applications are NFAT5 antibodies suitable for in research?

NFAT5 antibodies can be utilized across multiple experimental applications, enabling comprehensive investigation of this transcription factor. Based on validated protocols, NFAT5 antibodies are suitable for:

• Western blot (WB) analysis

• Immunocytochemistry/Immunofluorescence (ICC/IF)

• Immunoprecipitation (IP)

• Immunohistochemistry with paraffin-embedded sections (IHC-P)

• Chromatin immunoprecipitation (ChIP)

• Gel shift/Electrophoretic mobility shift assay (GS/EMSA)

Experimental validation has confirmed successful application in various tissues and cell lines, including MCF7 (human breast adenocarcinoma), Jurkat (T cell leukemia), Raji (Burkitt's lymphoma), U-2 OS (bone osteosarcoma), HeLa (epithelial adenocarcinoma), and NIH/3T3 (mouse embryo fibroblast) cells .

How are NFAT5 antibodies characterized and validated?

Characterization of NFAT5 antibodies involves rigorous evaluation of specificity, sensitivity, and reproducibility across multiple assays. Most commercially available NFAT5 antibodies are generated against synthetic peptides within human NFAT5 (specifically amino acids 1400-1500 for some products) . Validation typically includes:

• Western blot analysis demonstrating detection of the expected 165.8 kDa band

• Positive immunostaining patterns in known NFAT5-expressing tissues

• Confirmation of nuclear translocation under hypertonicity conditions

• Absence of signal in negative controls (e.g., samples without primary antibody)

• Cross-reactivity assessment across multiple species (human, mouse, rat, canine, etc.)

Researchers should review validation data specific to their experimental system, as reactivity may vary across different applications and species .

What are the optimal conditions for Western blot analysis using NFAT5 antibodies?

For optimal Western blot detection of NFAT5, researchers should implement the following methodological approach:

• Sample preparation: Load 25 μg of whole cell lysate per lane for cell lines like MCF7, Jurkat, or Raji

• Gel selection: Use 4-20% Tris-HCl polyacrylamide gradient gels to effectively resolve the large 165.8 kDa NFAT5 protein

• Transfer conditions: Transfer to PVDF membrane at low amperage overnight for complete transfer of high molecular weight proteins

• Blocking conditions: Block membranes with 5% Milk/TBS-0.1% Tween for at least 1 hour at room temperature

• Primary antibody incubation: Dilute NFAT5 antibody 1:1000 in blocking buffer and incubate overnight at 4°C on a rocking platform

• Washing steps: Wash membranes thoroughly in TBS-0.1% Tween 20 between antibody incubations

• Secondary antibody: Use goat anti-rabbit-HRP at 1:20,000 dilution for at least one hour

• Detection method: Employ chemiluminescent detection with appropriate exposure times

When troubleshooting, researchers should note that NFAT5 migrates close to its predicted weight of 165 kDa, and non-specific bands may appear at lower molecular weights.

How should I prepare samples for immunoprecipitation with NFAT5 antibodies?

Effective immunoprecipitation of NFAT5 requires careful attention to sample preparation and experimental conditions:

• Cell lysate preparation:

  • Prepare whole cell lysate from appropriate cell lines (e.g., U-2 OS)

  • Use 500 μg of whole cell lysate per immunoprecipitation reaction

  • Ensure complete cell lysis using appropriate buffer systems containing protease inhibitors

• Antibody complexing:

  • Incubate lysate with 3 μg of NFAT5 antibody overnight at 4°C on a rocking platform

  • Capture immune complexes using 50 μL Protein A/G Plus Agarose beads

  • Include a control sample containing only cell lysate without antibody

• Washing and elution:

  • Wash captured immune complexes thoroughly to remove non-specific interactions

  • Elute proteins using 5X Reducing Sample Loading Dye

  • Resolve samples on 4-20% Tris-HCl polyacrylamide gel for subsequent analysis

This approach has been validated for NFAT5 immunoprecipitation from human cell lines and can be adapted for other experimental systems with appropriate optimization.

What controls should be included when using NFAT5 antibodies for immunocytochemistry?

When performing immunocytochemistry/immunofluorescence with NFAT5 antibodies, inclusion of appropriate controls is essential for result interpretation:

• Negative controls:

  • Omission of primary antibody (secondary antibody only)

  • Use of isotype-matched irrelevant antibodies

  • Analysis of cells with known low or absent NFAT5 expression

• Positive controls:

  • Cell lines with validated NFAT5 expression (e.g., NIH/3T3, MCF7, HeLa)

  • Hypertonicity treatment to induce nuclear translocation of NFAT5

  • Counterstaining with complementary markers

• Technical considerations:

  • Fixation method: Formaldehyde fixation has been validated for NFAT5 detection

  • Antibody dilution: Test various dilutions (e.g., 1:20 to 1:200) to determine optimal signal-to-noise ratio

  • Incubation conditions: Overnight incubation at 4°C followed by PBS washing

  • Secondary antibody selection: DyLight-488 conjugated secondary antibodies work effectively

  • Counterstaining: Include F-Actin staining (Phalloidin) and nuclear staining (DAPI or Hoechst 33342)

Multi-channel imaging at 60X magnification allows visualization of NFAT5 localization relative to cytoskeletal and nuclear markers.

How can NFAT5 antibodies be utilized in chromatin immunoprecipitation (ChIP) studies?

NFAT5 antibodies have been successfully employed in ChIP assays to identify direct transcriptional targets and DNA binding sites:

• Experimental approach:

  • Expose cells to varying osmotic conditions (e.g., 300 and 450 mosM) to modulate NFAT5 binding

  • Perform ChIP using validated NFAT5 antibodies

  • Design primers flanking predicted NFAT5 consensus-binding sites in promoter regions

  • Quantify enrichment using both qualitative gel-based detection and quantitative PCR

• Case study: NFAT5 regulation of EDN1 gene:

  • ChIP using NFAT5 antibody successfully pulled down ET-1 promoter regions containing NFAT5 consensus binding sequences

  • Exposure to 450 mosM increased the intensity of PCR bands from ChIP samples compared to 300 mosM conditions

  • This approach identified NFAT5 as a direct transcriptional regulator of the EDN1 gene in inner medullary collecting duct cells

• Technical considerations:

  • Cross-linking conditions should be optimized for transcription factor ChIP

  • Sonication parameters require adjustment to generate appropriate fragment sizes

  • Include input controls and IgG negative controls

  • Design primers for both putative binding sites and negative control regions

  • Validate findings using reporter constructs with wild-type and mutated binding sites

What are the considerations when studying NFAT5 in hypertonicity response experiments?

When investigating NFAT5's role in hypertonicity responses, researchers should consider several methodological aspects:

• Experimental design parameters:

  • Cell type selection: Different cell types exhibit varying sensitivity to osmotic stress

  • Osmolarity conditions: Test dose-dependent responses (e.g., 300-450 mosM)

  • Time course: Monitor both acute and chronic adaptations to osmotic stress

  • Medium composition: Control for specific ionic concentrations vs. neutral osmolytes

• Readouts for NFAT5 activation:

  • Nuclear translocation: Assess by immunocytochemistry or nuclear/cytoplasmic fractionation

  • Transcriptional activity: Measure using reporter constructs with NFAT5 binding sites

  • Target gene expression: Quantify mRNA levels of known NFAT5-regulated genes

  • Protein-DNA binding: Evaluate using ChIP or electrophoretic mobility shift assays

• Loss-of-function approaches:

  • siRNA knockdown: Reduces NFAT5 expression transiently

  • CRISPR/Cas9 gene editing: Creates stable NFAT5-deficient cell lines by targeting specific exons (e.g., exon 4)

  • Dominant negative constructs: Interfere with NFAT5 function while maintaining expression

Studies in IMCD3 cells demonstrate that hypertonicity increases NFAT5 nuclear localization in a dose- and time-dependent manner, with corresponding increases in target gene expression .

How can NFAT5 antibodies be used to investigate transcriptional regulatory mechanisms?

NFAT5 antibodies serve as powerful tools for dissecting transcriptional regulatory mechanisms:

• Identification of direct target genes:

  • Combining ChIP with sequencing (ChIP-seq) to identify genome-wide binding patterns

  • ChIP-PCR focusing on candidate gene promoters (as demonstrated for the EDN1 gene)

  • Validation using reporter constructs with wild-type or mutated NFAT5 binding sites

• Analysis of multi-protein transcriptional complexes:

  • Co-immunoprecipitation to identify protein-protein interactions

  • Sequential ChIP (Re-ChIP) to detect co-occupancy at specific genomic loci

  • Proximity ligation assays to visualize protein interactions in situ

• Mechanistic dissection of regulatory pathways:

  • Combine NFAT5 antibody-based techniques with:

    • Site-directed mutagenesis of binding sites

    • Deletion analysis of promoter regions

    • Reporter assays with varying osmotic conditions

    • Analysis in wild-type versus NFAT5-deficient cells

As demonstrated in IMCD studies, mutation of two NFAT5 consensus-binding sites in the ET-1 promoter abolished hypertonicity-induced reporter activity, confirming direct regulation by NFAT5 .

Why might I observe multiple bands in Western blots using NFAT5 antibodies?

Multiple bands in NFAT5 Western blots can result from several biological and technical factors:

• Biological explanations:

  • Alternative splicing: NFAT5 exists in multiple isoforms

  • Post-translational modifications: Phosphorylation states affect migration

  • Proteolytic processing: Cleavage products may be detected

  • Species differences: Orthologs may have slightly different molecular weights

• Technical considerations:

  • Sample preparation: Incomplete denaturation or proteolysis during extraction

  • Gel percentage: Inadequate resolution of high molecular weight proteins

  • Transfer efficiency: Incomplete transfer of large proteins

  • Antibody specificity: Cross-reactivity with related proteins

• Validation approaches:

  • Compare band patterns across multiple cell lines with known NFAT5 expression

  • Include positive controls (e.g., MCF7, Jurkat, Raji whole cell lysates)

  • Perform peptide competition assays

  • Compare results with multiple NFAT5 antibodies targeting different epitopes

The predicted band size for human NFAT5 is approximately 165 kDa, which should serve as the primary reference point when evaluating Western blot results .

How can I validate the specificity of my NFAT5 antibody?

Comprehensive validation of NFAT5 antibody specificity requires multiple complementary approaches:

• Genetic approaches:

  • Compare signal in wild-type versus NFAT5 knockdown cells (siRNA)

  • Analyze CRISPR/Cas9-mediated NFAT5 knockout cells (e.g., targeting exon 4)

  • Rescue experiments with exogenous NFAT5 expression

• Biochemical validation:

  • Peptide competition/blocking experiments

  • Pre-adsorption tests with immunizing peptide

  • Immunoprecipitation followed by mass spectrometry identification

  • Comparison across multiple antibodies targeting different NFAT5 epitopes

• Functional validation:

  • Correlation of signal with known biological responses (e.g., hypertonicity-induced nuclear translocation)

  • Detection of expected molecular weight protein (165.8 kDa)

  • Demonstration of expected subcellular localization patterns

  • Loss of signal in negative control samples

Studies have demonstrated specificity by showing reduced antibody signals in NFAT5-deficient IMCD3 cells generated via CRISPR/Cas9-mediated targeting of exon 4 .

What approaches can help resolve inconsistent results with NFAT5 antibodies across different experimental conditions?

When facing inconsistent results with NFAT5 antibodies, systematic troubleshooting approaches can help identify and resolve issues:

• Protocol standardization:

  • Establish consistent sample preparation methods

  • Standardize antibody dilutions and incubation conditions

  • Control for lot-to-lot variation in antibodies

  • Maintain consistent technical parameters (e.g., gel percentage, transfer conditions)

• Biological variables to control:

  • Cell confluence and passage number

  • Osmotic conditions during cell culture

  • Serum starvation effects (growth arrest for 24h before experiments)

  • Timing of sample collection (NFAT5 expression/localization changes over time)

• Application-specific considerations:

  • Western blot: Optimize lysis buffers and detergent concentrations

  • Immunocytochemistry: Test multiple fixation and permeabilization methods

  • ChIP: Adjust crosslinking time and sonication parameters

  • Immunoprecipitation: Vary antibody-to-lysate ratios and washing stringency

• Analytical approaches:

  • Include biological and technical replicates

  • Quantify results relative to appropriate loading controls

  • Apply statistical analysis to determine significance of observations

  • Document methodological details comprehensively

How are NFAT5 antibodies being used to study the relationship between osmotic stress and cellular function?

NFAT5 antibodies enable investigation of fundamental links between osmotic stress responses and various cellular functions:

• Antibody productivity in hybridoma cells:

  • NFAT5 expression increases significantly in hybridoma cells exposed to hypertonic medium

  • RNA interference to downregulate NFAT5 reduces antibody productivity in isotonic medium

  • NFAT5 appears essential for optimal antibody productivity in hybridoma cells

  • These findings have implications for monoclonal antibody production technologies

• Renal physiology and sodium homeostasis:

  • NFAT5 directly regulates EDN1 gene expression in inner medullary collecting duct cells

  • Hypertonicity enhances ET-1 production in a NFAT5-dependent manner

  • This mechanism represents an important pathway by which body Na+ homeostasis is maintained

  • NFAT5 antibodies enable ChIP studies identifying direct transcriptional regulation of osmotic response genes

• Methodological innovations:

  • Combining NFAT5 antibodies with CRISPR/Cas9 gene editing technology

  • Development of reporter constructs with NFAT5 binding sites for functional studies

  • Cross-disciplinary applications across immunology, nephrology, and cell physiology research

These diverse applications highlight the versatility of NFAT5 antibodies as tools for investigating fundamental biological processes related to osmotic stress responses.

What considerations should researchers keep in mind when studying NFAT5 across different cell types?

NFAT5 expression and function vary significantly across cell types, requiring tailored experimental approaches:

• Cell type-specific expression patterns:

  • NFAT5 is expressed in multiple tissues including kidneys, brain, and immune cells

  • Expression levels may vary substantially between cell types

  • Some applications have been validated in specific cell lines: MCF7, Jurkat, Raji, U-2 OS, HeLa, NIH/3T3

  • Different antibody dilutions may be required for optimal results in different cell types (from 1:20 to 1:1000)

• Functional differences across tissues:

  • Renal cells: Focus on osmoregulatory functions and Na+ homeostasis

  • Immune cells: Consider roles in T cell activation and inflammatory responses

  • Hybridoma cells: Examine impacts on antibody production capacity

  • Neural tissues: Investigate osmotic stress responses in specialized environments

• Experimental design considerations:

  • Baseline osmolarity appropriate for the cell type under study

  • Cell-specific markers to confirm identity and phenotype

  • Appropriate positive and negative control cell lines

  • Validation of antibody specificity in each experimental system

• Species-specific considerations:

  • Antibodies may have differential reactivity across human, mouse, rat, and other species

  • Sequence divergence at epitope regions may affect antibody binding

  • Consider species-matched positive controls when available

NFAT5's ubiquitous expression in various organs not normally exposed to hypertonic environments suggests broader physiological roles beyond osmotic stress responses .

How can researchers design experiments to distinguish between osmotic and non-osmotic functions of NFAT5?

Distinguishing between osmotic and non-osmotic functions of NFAT5 requires carefully designed experimental approaches:

• Experimental strategies:

  • Compare NFAT5 activity under isotonic versus hypertonic conditions

  • Analyze NFAT5-dependent processes in cell types not normally exposed to osmotic stress

  • Identify stimulus-specific versus common NFAT5 target genes

  • Investigate NFAT5 activation by non-osmotic stimuli (e.g., inflammatory signals)

• Case study: Hybridoma cells:

  • NFAT5 downregulation reduced antibody productivity in isotonic medium

  • This suggests NFAT5 has essential functions even under normal osmotic conditions

  • Cell proliferation was not affected by NFAT5 downregulation, indicating specificity

  • These findings point to a role for NFAT5 in monoclonal antibody production independent of osmotic stress

• Molecular approaches:

  • ChIP-seq under different osmotic conditions to identify condition-specific binding sites

  • Mutation analysis of NFAT5 domains to separate osmotic sensing from other functions

  • Interactome studies to identify condition-specific protein-protein interactions

  • Computational analysis of promoter elements in osmotic versus non-osmotic target genes

• Technical considerations:

  • Precise control of osmolarity conditions

  • Distinguish between acute versus chronic responses

  • Consider cell type-specific thresholds for hypertonicity responses

  • Account for secondary effects of osmotic stress